SOPH (Sophia Genetics) Total Current Assets: $95.81 Mil (As of Mar. 2026)


SOPH Sophia Genetics SA SOPH
73 GF Score
Price $5.36
GF Value $5.04
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Sophia Genetics Total Current Assets?

Sophia Genetics SOPH -4.12% 73 Total Current Assets is $95.81 Mil as of Mar. 2026. GuruFocus rates SOPH with a GF Score™ of 73/100 and a GF Value™ of $5.04 (Fairly Valued). The stock has 6 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Sophia Genetics's total current assets for the quarter that ended in Mar. 2026 was $95.81 Mil.

Sophia Genetics  (NAS:SOPH) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Sophia Genetics's Liquidation Value for the quarter that ended in Mar. 2026 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=65.392-111.307+0.75 * 13.544+0.5 * 7.086
=-32.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sophia Genetics Total Current Assets Related Terms

Sophia Genetics Total Current Assets Historical Data

* Premium members only.

The historical data trend for Sophia Genetics's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sophia Genetics Total Current Assets Chart

Sophia Genetics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Assets
Get a 7-Day Free Trial 282.86 196.26 148.05 99.41 99.08

Sophia Genetics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.05 117.03 103.48 99.08 95.81
SOPH
73GF Score
Sophia Genetics SA SOPH
Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sophia Genetics Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Sophia Genetics's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=70.289+16.525+6.351+5.914
=99.08

Sophia Genetics's Total Current Assets for the quarter that ended in Mar. 2026 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=65.392+14.312+7.086+9.021
=95.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of $95.81 Mil mean?
Sophia Genetics (SOPH) has a Total Current Assets of $95.81 Mil as of Mar. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Sophia Genetics and its competitors.
Is Sophia Genetics' Total Current Assets too high?
Sophia Genetics' current Total Current Assets is $95.81 Mil. Overall, Sophia Genetics has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sophia Genetics' Total Current Assets compare to WEAV and NRC?
Sophia Genetics' Total Current Assets of $95.81 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Healthcare Providers & Services company?
A good Total Current Assets depends on the Healthcare Providers & Services industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Sophia Genetics and its competitors. Sophia Genetics's current Total Current Assets is $95.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sophia Genetics stock overvalued right now?
Based on GuruFocus' analysis, Sophia Genetics (SOPH) is currently considered Fairly Valued. The stock's GF Value™ is $5.04, compared to a current price of $5.36 — trading 6.3% above its estimated fair value. The current Total Current Assets is $95.81 Mil. Sophia Genetics' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For Sophia Genetics (SOPH), the current Total Current Assets is $95.81 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sophia Genetics (SOPH) Overvalued in 2026?

Based on GuruFocus' analysis, Sophia Genetics stock appears to be overvalued. The current stock price of $5.36 is trading 6.3% above its estimated GF Value™ of $5.04. GuruFocus considers Sophia Genetics to be Fairly Valued.

Key valuation signals for SOPH:

  • Total Current Assets: $95.81 Mil
  • GF Value™: $5.04 vs. price of $5.36 (6.3% above fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the SOPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sophia Genetics Business Description

Other Exchanges 90B:Germany
Address La Piece 12, Rolle, CHE, CH-1180
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
73GF Score

Get the complete analysis for SOPH

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.36
Price
$5.04
GF Value